Regencell Bioscience is the top performing pharma stock YTD
Source: SeekingAlpha
2025-12-22 23:47:10 ET
More on healthcare stocks
- My S&P 500 Prediction On Sector Outperformers And Laggards In 2026
- IHI: A Passive ETF For Medical Device Exposure
- Regencell Bioscience: Material Weaknesses Add To Woes
- Abivax is the top performing biotechnology stock YTD
- PACS Group is the top performing healthcare facilities' stock YTD
Read the full article on Seeking Alpha
For further details see:
Regencell Bioscience is the top performing pharma stock YTD
Terns Pharmaceuticals Inc.
NASDAQ: TERN
TERN Trading
1.65% G/L:
$41.87 Last:
682,914 Volume:
$40.66 Open:
TERN Latest News
March 05, 2026 10:14:13 am
Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing
February 25, 2026 04:05:00 pm
Terns Pharmaceuticals to Participate in Upcoming March Investor Conferences
February 20, 2026 12:22:22 am
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing
February 17, 2026 12:52:00 pm
Fund Discloses $35 Million Biotech Buy Amid Staggering 830% Terns Stock Surge
TERN Stock Data
$3,951,236,778
84,980,644
0.19%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
Foster City
